CORD-19:68a7101a90454172c91785d8c352f776a82df5d4 / 854991-855283
Annnotations
{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/68a7101a90454172c91785d8c352f776a82df5d4","sourcedb":"CORD-19","sourceid":"68a7101a90454172c91785d8c352f776a82df5d4","text":"We have identified miR29, which targets T-bet and interferon gamma (IFNγ), as important to study in MS. We reasoned that MS patients might have altered levels of miR 29 and indeed found that purified CD4+ T cells from MS patients had lower basal levels of miR-29 relative to control patients.","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"T46246","span":{"begin":0,"end":103},"obj":"Sentence"},{"id":"T91331","span":{"begin":104,"end":292},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T46246","pred":"source","obj":"CORD-19-Sentences"},{"subj":"T91331","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"Epistemic_Statements","denotations":[{"id":"T1889","span":{"begin":0,"end":292},"obj":"Epistemic_statement"}],"attributes":[{"subj":"T1889","pred":"source","obj":"Epistemic_Statements"}]},{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T112","span":{"begin":0,"end":103},"obj":"Sentence"},{"id":"T113","span":{"begin":104,"end":292},"obj":"Sentence"}],"attributes":[{"subj":"T112","pred":"source","obj":"CORD-19_Custom_license_subset"},{"subj":"T113","pred":"source","obj":"CORD-19_Custom_license_subset"}]},{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T3616","span":{"begin":100,"end":102},"obj":"Body_part"},{"id":"T3617","span":{"begin":121,"end":123},"obj":"Body_part"},{"id":"T3618","span":{"begin":218,"end":220},"obj":"Body_part"}],"attributes":[{"id":"A3616","pred":"uberon_id","subj":"T3616","obj":"http://purl.obolibrary.org/obo/UBERON_0001877"},{"id":"A3617","pred":"uberon_id","subj":"T3617","obj":"http://purl.obolibrary.org/obo/UBERON_0001877"},{"id":"A3618","pred":"uberon_id","subj":"T3618","obj":"http://purl.obolibrary.org/obo/UBERON_0001877"},{"subj":"T3616","pred":"source","obj":"CORD-19-PD-UBERON"},{"subj":"T3617","pred":"source","obj":"CORD-19-PD-UBERON"},{"subj":"T3618","pred":"source","obj":"CORD-19-PD-UBERON"}]},{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T5381","span":{"begin":100,"end":102},"obj":"Disease"},{"id":"T5382","span":{"begin":121,"end":123},"obj":"Disease"},{"id":"T5383","span":{"begin":218,"end":220},"obj":"Disease"},{"id":"T27096","span":{"begin":100,"end":102},"obj":"Disease"},{"id":"T5345","span":{"begin":121,"end":123},"obj":"Disease"},{"id":"T5346","span":{"begin":218,"end":220},"obj":"Disease"}],"attributes":[{"id":"A5381","pred":"mondo_id","subj":"T5381","obj":"http://purl.obolibrary.org/obo/MONDO_0005301"},{"id":"A5382","pred":"mondo_id","subj":"T5382","obj":"http://purl.obolibrary.org/obo/MONDO_0005301"},{"id":"A5383","pred":"mondo_id","subj":"T5383","obj":"http://purl.obolibrary.org/obo/MONDO_0005301"},{"id":"A93574","pred":"mondo_id","subj":"T27096","obj":"http://purl.obolibrary.org/obo/MONDO_0005301"},{"id":"A7225","pred":"mondo_id","subj":"T5345","obj":"http://purl.obolibrary.org/obo/MONDO_0005301"},{"id":"A68650","pred":"mondo_id","subj":"T5346","obj":"http://purl.obolibrary.org/obo/MONDO_0005301"},{"subj":"T5381","pred":"source","obj":"CORD-19-PD-MONDO"},{"subj":"T5382","pred":"source","obj":"CORD-19-PD-MONDO"},{"subj":"T5383","pred":"source","obj":"CORD-19-PD-MONDO"},{"subj":"T27096","pred":"source","obj":"CORD-19-PD-MONDO"},{"subj":"T5345","pred":"source","obj":"CORD-19-PD-MONDO"},{"subj":"T5346","pred":"source","obj":"CORD-19-PD-MONDO"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#9eec93","default":true},{"id":"Epistemic_Statements","color":"#ec93b8"},{"id":"CORD-19_Custom_license_subset","color":"#93d2ec"},{"id":"CORD-19-PD-UBERON","color":"#ecec93"},{"id":"CORD-19-PD-MONDO","color":"#d293ec"}]}]}}